A detailed history of Wedbush Securities Inc transactions in Sanofi stock. As of the latest transaction made, Wedbush Securities Inc holds 11,345 shares of SNY stock, worth $616,487. This represents 0.02% of its overall portfolio holdings.

Number of Shares
11,345
Previous 17,068 33.53%
Holding current value
$616,487
Previous $828,000 21.01%
% of portfolio
0.02%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$48.54 - $58.53 $277,794 - $334,967
-5,723 Reduced 33.53%
11,345 $654,000
Q2 2024

Aug 06, 2024

BUY
$45.39 - $50.36 $191,772 - $212,771
4,225 Added 32.9%
17,068 $828,000
Q1 2024

May 14, 2024

BUY
$45.75 - $52.48 $176,961 - $202,992
3,868 Added 43.1%
12,843 $624,000
Q4 2023

Feb 12, 2024

SELL
$43.13 - $54.79 $59,864 - $76,048
-1,388 Reduced 13.39%
8,975 $446,000
Q3 2023

Nov 14, 2023

SELL
$50.95 - $55.2 $28,379 - $30,746
-557 Reduced 5.1%
10,363 $556,000
Q2 2023

Aug 14, 2023

SELL
$50.45 - $57.18 $71,739 - $81,309
-1,422 Reduced 11.52%
10,920 $589,000
Q1 2023

May 09, 2023

SELL
$45.86 - $54.45 $32,744 - $38,877
-714 Reduced 5.47%
12,342 $672,000
Q4 2022

Jan 31, 2023

BUY
$38.86 - $48.55 $15,660 - $19,565
403 Added 3.19%
13,056 $632,000
Q3 2022

Oct 18, 2022

SELL
$37.22 - $100.5 $34,614 - $93,465
-930 Reduced 6.85%
12,653 $481,000
Q2 2022

Jul 21, 2022

BUY
$48.99 - $57.46 $7,936 - $9,308
162 Added 1.21%
13,583 $679,000
Q1 2022

Apr 19, 2022

SELL
$48.48 - $53.65 $22,591 - $25,000
-466 Reduced 3.36%
13,421 $689,000
Q4 2021

Jan 13, 2022

SELL
$47.07 - $52.35 $19,769 - $21,987
-420 Reduced 2.94%
13,887 $695,000
Q3 2021

Oct 08, 2021

SELL
$47.89 - $53.12 $1,149 - $1,274
-24 Reduced 0.17%
14,307 $689,000
Q2 2021

Jul 27, 2021

SELL
$49.36 - $54.25 $86,478 - $95,046
-1,752 Reduced 10.89%
14,331 $754,000
Q1 2021

Apr 26, 2021

BUY
$45.46 - $50.51 $170,884 - $189,867
3,759 Added 30.5%
16,083 $795,000
Q4 2020

Feb 16, 2021

SELL
$45.3 - $51.62 $14,994 - $17,086
-331 Reduced 2.62%
12,324 $599,000
Q3 2020

Oct 20, 2020

SELL
$49.47 - $53.77 $8,113 - $8,818
-164 Reduced 1.28%
12,655 $635,000
Q2 2020

Jul 16, 2020

SELL
$42.91 - $52.5 $235,404 - $288,015
-5,486 Reduced 29.97%
12,819 $654,000
Q1 2020

Apr 17, 2020

BUY
$38.02 - $51.66 $71,249 - $96,810
1,874 Added 11.41%
18,305 $800,000
Q4 2019

Jan 16, 2020

SELL
$44.25 - $50.86 $6,549 - $7,527
-148 Reduced 0.89%
16,431 $825,000
Q3 2019

Oct 17, 2019

BUY
$40.34 - $46.64 $27,874 - $32,228
691 Added 4.35%
16,579 $768,000
Q2 2019

Aug 01, 2019

BUY
$40.43 - $44.3 $49,365 - $54,090
1,221 Added 8.32%
15,888 $687,000
Q1 2019

Apr 17, 2019

SELL
$40.83 - $45.43 $22,048 - $24,532
-540 Reduced 3.55%
14,667 $649,000
Q4 2018

Jan 31, 2019

SELL
$41.48 - $45.59 $191,305 - $210,261
-4,612 Reduced 23.27%
15,207 $660,000
Q3 2018

Nov 13, 2018

SELL
$40.0 - $44.84 $9,680 - $10,851
-242 Reduced 1.21%
19,819 $885,000
Q2 2018

Aug 03, 2018

BUY
$37.63 - $41.22 $24,271 - $26,586
645 Added 3.32%
20,061 $803,000
Q1 2018

May 01, 2018

BUY
$38.98 - $45.76 $6,743 - $7,916
173 Added 0.9%
19,416 $778,000
Q4 2017

Feb 09, 2018

SELL
$42.86 - $50.61 $5,400 - $6,376
-126 Reduced 0.65%
19,243 $827,000
Q3 2017

Oct 31, 2017

BUY
$47.04 - $50.34 $911,117 - $975,035
19,369
19,369 $964,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $136B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Wedbush Securities Inc Portfolio

Follow Wedbush Securities Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wedbush Securities Inc with notifications on news.